My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Becton Dickinson (NY:BDX)

171.89 +8.91 (+5.47%)

Streaming Delayed Price Updated: 3:25 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation ↗

December 21, 2024

Becton, Dickinson and Co. pays a $175 million civil penalty and Express fails to disclose its former CEO's full compensation.

Via Benzinga

(BDX) - Analyzing Becton Dickinson's Short Interest ↗

December 13, 2024

Via Benzinga

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

December 05, 2024

Carl Hull to Retire as Executive Chairman

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

13 Healthcare Sector Stocks With Healthy Valuation ↗

December 05, 2024

We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty...

Via Talk Markets

Topics Stocks Stocks / Equities

Price Over Earnings Overview: Becton Dickinson ↗

October 23, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts ↗

October 01, 2024

Via Benzinga

(BDX) - Analyzing Becton Dickinson's Short Interest ↗

August 23, 2024

Via Benzinga

Looking Into Becton Dickinson's Recent Short Interest ↗

August 07, 2024

Via Benzinga

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps ↗

November 26, 2024

Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures.

Via Benzinga

Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It ↗

November 15, 2024

Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38.

Via Benzinga

Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike ↗

November 07, 2024

The U.S.

Via Benzinga

Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth ↗

November 07, 2024

BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 billion-$22.1 billion sales and EPS of $14.25-$14.60.

Via Benzinga

Key Takeaways From Becton Dickinson Analyst Ratings ↗

July 26, 2024

Via Benzinga

Looking Into Becton Dickinson's Recent Short Interest ↗

July 17, 2024

Via Benzinga

Peering Into Becton Dickinson's Recent Short Interest ↗

June 10, 2024

Via Benzinga

Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29 ↗

September 29, 2024

Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights...

Via Talk Markets

Top Analyst Reports For Nvidia, American Express & Wells Fargo ↗

September 27, 2024

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., American Express Co., and Wells Fargo & Co., as well as two micro-cap stocks Elite Pharmaceuticals, Inc....

Via Talk Markets

The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024 ↗

August 08, 2024

Explore the best dividend payouts from leading companies for sustainable, steady and growing income streams.

Via InvestorPlace

8 Health Care Stocks With Whale Alerts In Today's Session ↗

August 01, 2024

Via Benzinga

Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off ↗

July 23, 2024

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and...

Via Benzinga

3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends ↗

July 11, 2024

With the baby boom turning into a retirement bonanza, investors should consider these senior-focused healthcare stocks.

Via InvestorPlace

Topics Retirement

UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades' ↗

July 11, 2024

UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591.

Via Benzinga

Boing! 7 Undervalued Stocks That Could Surprise the Skeptics. ↗

July 01, 2024

The market previously supported a higher multiple for these undervalued stocks, making them attractive contrarian targets.

Via InvestorPlace

Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review ↗

June 07, 2024

The Nasdaq and S&P 500 hit record highs, but small caps retreated.

Via Investor's Business Daily

Topics Stocks

BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details ↗

June 03, 2024

BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring...

Via Benzinga

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal ↗

June 03, 2024

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.

Via Investor's Business Daily

Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs ↗

May 21, 2024

Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds.

Via InvestorPlace

Topics World Trade

Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy' ↗

May 15, 2024

Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese...

Via Benzinga

Topics World Trade

MarketBeat Week in Review – 4/29 - 5/3

May 04, 2024

Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024

Via MarketBeat

Topics Economy Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.